LEADER 01021nam0-22003131i-450- 001 990001611190403321 005 20100118163915.0 035 $a000161119 035 $aFED01000161119 035 $a(Aleph)000161119FED01 035 $a000161119 100 $a20030910d1980----km-y0itay50------ba 101 0 $aeng 102 $aUS 200 1 $aEconomic growth, equity and agricultural development in the Dominican Republic$fLehman B. Fletcher, Eric Graber 210 $aAmes, Iowa$cDepartment of Economics$d1980 215 $aX, 465 p.$d28 cm 225 1 $aInternational studies in economics. Monograph$v12 610 0 $aEconomia agraria$aAmerica latina 676 $a333 700 1$aFletcher,$bLehman B.$068162 701 1$aGraber,$bEric$068524 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990001611190403321 952 $a60 333 B 54/12$b48234$fFAGBC 959 $aFAGBC 996 $aEconomic growth, equity and agricultural development in the Dominican Republic$9368824 997 $aUNINA LEADER 01816nam 2200373Ia 450 001 996386281003316 005 20221108103243.0 035 $a(CKB)4940000000080670 035 $a(EEBO)2240893758 035 $a(OCoLC)13459469 035 $a(EXLCZ)994940000000080670 100 $a19860421d1658 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 10$aRecords arithmetick, or, The ground of arts$b[electronic resource] $eteaching the perfect work and practice of arithmetic both in whole numbers and fractions after a more easie and exact form then in former time hath been set forth /$fmade by M. Robert Record ... ; afterward augmented by M. John Dee ; and since enlarged with a third part of rules of practice abridged into a briefer method then hitherto hath been published ... by John Mellis ; and now diligently perused, corrected, illustrated and enlarged with an appendix of figurative numbers ... and new tables of interest ... the first calculated by R.C. ... and the latter diligently calculated by Ro. Hartwell .. 210 $aLondon $cPrinted by James Flesher and are to be sold by Joseph Crawford ...$d1658 215 $a[21], 535 p 300 $aImperfect: pages stained. 300 $aReproduction of original in the University of Illinois (Urbana-Champaign Campus). Library. 330 $aeebo-0167 606 $aArithmetic$vEarly works to 1800 615 0$aArithmetic 700 $aRecord$b Robert$f1510?-1558.$01003280 701 $aDee$b John$f1527-1608.$0684762 701 $aMellis$b John$ffl. 1588.$01003281 701 $aHartwell$b Robert$01003282 801 0$bEAG 801 1$bEAG 801 2$bUMI 801 2$bWaOLN 906 $aBOOK 912 $a996386281003316 996 $aRecords arithmetick, or, The ground of arts$92303374 997 $aUNISA LEADER 04017nam 2201009z- 450 001 9910566486303321 005 20220506 035 $a(CKB)5680000000037516 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/80940 035 $a(oapen)doab80940 035 $a(EXLCZ)995680000000037516 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aRheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (178 p.) 311 08$a3-0365-3641-8 311 08$a3-0365-3642-6 330 $aThis e-book summarises the latest advances in the rheumatic diseases with a focus on the recent efforts of vascular and pulmonary manifestations and anticipate the new and future directions of these research topic. Rheumatic diseases represent a heterogeneous group of severe autoimmune disorders. The present Special Issue aims to provide an overview of the complexity of vascular and pulmonary manifestations of rheumatologic diseases and helps in knowledge to manage them. The eleven published articles here collected underline the complexity of rheumatic diseases and the difficult to treated them. The manuscripts provide an overview of the pathophysiology and current treatment regimes of these disorders, highlighting tools which assist with diagnosis, risk stratification and therapy. Finally, we underline the importance of a multidisciplinary team working using the skills of clinicians, radiologists, and pathologists. 517 $aRheumatic Diseases 606 $aMedicine and Nursing$2bicssc 606 $aPharmacology$2bicssc 610 $a3D-echocardiography 610 $aairway disease 610 $aantifibrotic agents 610 $acardiopulmonary exercise testing 610 $aconnective tissue diseases 610 $aCOVID-19 610 $aCX3CL1/fractalkine 610 $aCX3CR1 610 $adiffuse alveolar hemorrhage 610 $aefficacy 610 $afibromyalgia 610 $agastrointestinal symptoms 610 $aheart failure 610 $ahigh-resolution computed tomography 610 $ainfection 610 $ainflammatory response 610 $ainterstitial lung disease 610 $ainterstitial lung diseases 610 $aIPF 610 $aM1 macrophage 610 $aM2 macrophage 610 $amicrovascular involvement 610 $anailfold capillaroscopy 610 $aosteopontin 610 $aoutcome 610 $apharmacological interactions 610 $apleurisy 610 $aPMR 610 $apolymyalgia rheumatica 610 $aprobiotic 610 $aprogressive fibrosing ILD 610 $apulmonary arterial hypertension 610 $apulmonary function tests 610 $apulmonary involvement 610 $arheumatic 610 $arheumatoid arthritis 610 $ascleroderma 610 $ashrinking lung syndrome 610 $aSKG mice 610 $asystemic lupus erythematosus 610 $asystemic sclerosis 610 $at-vns 610 $atargeted therapy 610 $atolerability 610 $aUIP 610 $avagus nerve stimulation 610 $aventricular function 610 $aventricular-arterial coupling 610 $aVSL#3® 615 7$aMedicine and Nursing 615 7$aPharmacology 700 $aRuaro$b Barbara$4edt$01322436 702 $aSalton$b Francesco$4edt 702 $aConfalonieri$b Paola$4edt 702 $aRuaro$b Barbara$4oth 702 $aSalton$b Francesco$4oth 702 $aConfalonieri$b Paola$4oth 906 $aBOOK 912 $a9910566486303321 996 $aRheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations$93035001 997 $aUNINA